संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

micro labs limited - tafluprost (unii: 1o6wq6t7g3) (tafluprost - unii:1o6wq6t7g3) - tafluprost ophthalmic solution, 0.0015% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. none. pregnancy category c. teratogenic effects: in embryo-fetal development studies in rats and rabbits, tafluprost administered intravenously was teratogenic. tafluprost caused increases in post-implantation losses in rats and rabbits and reductions in fetal body weights in rats. tafluprost also increased the incidence of vertebral skeletal abnormalities in rats and the incidence of skull, brain and spine malformations in rabbits. in rats, there were no adverse effects on embryo-fetal development at a dose of 3 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid that were 343 times the maximum clinical exposure based on c max . in rabbits, effects were seen at a tafluprost dose of 0.03 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid during organogenesis that were approximately 5 times higher than the

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

prasco laboratories - tafluprost (unii: 1o6wq6t7g3) (tafluprost - unii:1o6wq6t7g3) - tafluprost ophthalmic solution 0.0015% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. none. pregnancy category c. teratogenic effects: in embryo-fetal development studies in rats and rabbits, tafluprost administered intravenously was teratogenic. tafluprost caused increases in post-implantation losses in rats and rabbits and reductions in fetal body weights in rats. tafluprost also increased the incidence of vertebral skeletal abnormalities in rats and the incidence of skull, brain and spine malformations in rabbits. in rats, there were no adverse effects on embryo-fetal development at a dose of 3 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid that were 343 times the maximum clinical exposure based on cmax . in rabbits, effects were seen at a tafluprost dose of 0.03 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid during organogenesis that were approximately 5 times higher than the clinical exposu

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

sandoz inc - tafluprost (unii: 1o6wq6t7g3) (tafluprost - unii:1o6wq6t7g3) - tafluprost ophthalmic solution 0.0015% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. none. teratogenic effects in embryo-fetal development studies in rats and rabbits, tafluprost administered intravenously was teratogenic. tafluprost caused increases in post-implantation losses in rats and rabbits and reductions in fetal body weights in rats. tafluprost also increased the incidence of vertebral skeletal abnormalities in rats and the incidence of skull, brain and spine malformations in rabbits. in rats, there were no adverse effects on embryo-fetal development at a dose of 3 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid that were 343 times the maximum clinical exposure based on cmax . in rabbits, effects were seen at a tafluprost dose of 0.03 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid during organogenesis that were approximately 5 times higher than the clinical exposure based on cmax . at t

स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tafluprost; tafluprost - kapljice za oko, raztopina - tafluprost 15 µg / 1 ml  tafluprost15 µg / 1 ml; tafluprost 15 µg / 1 ml - tafluprost

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

akorn - tafluprost (unii: 1o6wq6t7g3) (tafluprost - unii:1o6wq6t7g3) - tafluprost 0.0045 mg in 0.3 ml - zioptan® (tafluprost ophthalmic solution) 0.0015% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. none. pregnancy category c. teratogenic effects: in embryo-fetal development studies in rats and rabbits, tafluprost administered intravenously was teratogenic. tafluprost caused increases in post-implantation losses in rats and rabbits and reductions in fetal body weights in rats. tafluprost also increased the incidence of vertebral skeletal abnormalities in rats and the incidence of skull, brain and spine malformations in rabbits. in rats, there were no adverse effects on embryo-fetal development at a dose of 3 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid that were 343 times the maximum clinical exposure based on cmax . in rabbits, effects were seen at a tafluprost dose of 0.03 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid during organogenesis that were approximately 5 times higher than the cli

नीदरलैंड - डच - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

bmodesto b.v. - tafluprost - oogdruppels, oplossing - dinatriumedetaat 2-water ; glycerol (e 422) ; natriumdiwaterstoffosfaat 2-water (e 339) ; natriumhydroxide (e 524) ; polysorbaat 80 (e 433) ; water voor injectie ; zoutzuur (e 507), - tafluprost

नीदरलैंड - डच - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

dr. fisher farma b.v. schutweg 23 8243 pc lelystad - tafluprost - oogdruppels, oplossing - dinatriumedetaat 2-water ; glycerol (e 422) ; natriumdiwaterstoffosfaat 2-water (e 339) ; natriumhydroxide (e 524) ; polysorbaat 80 (e 433) ; water voor injectie ; zoutzuur (e 507), - tafluprost

नीदरलैंड - डच - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

dr. fisher farma b.v. schutweg 23 8243 pc lelystad - tafluprost - oogdruppels, oplossing - dinatriumedetaat 2-water ; glycerol (e 422) ; natriumdiwaterstoffosfaat 2-water (e 339) ; natriumhydroxide (e 524) ; polysorbaat 80 (e 433) ; water voor injectie ; zoutzuur (e 507), - tafluprost

स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tafluprost; timolol; tafluprost - kapljice za oko, raztopina - tafluprost 0,015 mg / 1 ml  timolol5 mg / 1 ml  tafluprost0,015 mg / 1 ml; timolol 5 mg / 1 ml  tafluprost0,015 mg / 1 ml; tafluprost 0,015 mg / 1 ml - timolol, kombinacije

स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tafluprost; timolol; tafluprost - kapljice za oko, raztopina - tafluprost 0,015 mg / 1 ml  timolol5 mg / 1 ml  tafluprost0,015 mg / 1 ml; timolol 5 mg / 1 ml  tafluprost0,015 mg / 1 ml; tafluprost 0,015 mg / 1 ml - timolol, kombinacije